chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hello, Wednesday afternoon april 7th at 1630 I took the first dose of the moderna vaccine. A few hours later I felt like my eyeballs were "swimming" inside of my head, and I felt really dizzy and spacey with the colors on the tv screen seeming blurry. The following day I woke up and my fingers and toes were numb, headache, chills, dizzy, and felt forgetful, fatigue, and "out of it." I felt nauseous, like there were vomit chunks in the back of my throat. Friday I woke up, went to work and had to come home early because I could barely hold a conversation still like the day before, screen was blurry, felt nauseous, and fingers and toes are numb. I still have taste and smell. Saturday april 10th, i have a little bit more energy but still feel weak, dizzy, headache and fatigued. I am allergic to amoxicillan...does this tie in? My second dose is set for May 5th. Primary doctor received email from me tonight
MEMBER BECAME DIZZY AFTER LEAVING THE OBSERVATION AREA. SHE WAS LEANING AGAIN WALL NEAR TRIAGE 1 AREA AND EMT OBSERVED HER, RETRIEVED WHEELCHAIR FROM TRIAGE 1 AND BROUGH HER FOR EVALUATION BACK TO TRIAGE 1. ON SITE CLINICAL LEAD AND PHYSICIAN ON SITE NOTIFIED. VITAL SITES ASSESSED AND REMAINED STABLE: 149/77 WITH HEART RATE OF 76. CONTINUED TO MONITOR WITH SYMPTOM RESOLUTION FOR A TOTAL OF 30 MINUTES. SHE WAS WHEELED TO FAMILY MEMBER AT CONCLUSION OF RECOVERY BY EMT.
Blood test after second dose, result came back as negative- no antibody count; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Blood test after second dose, result came back as negative- no antibody count) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Depression, Hypercholesterolemia and Sleep disorder. Concurrent medical conditions included Rheumatoid arthritis since 1985, Supraventricular tachycardia since 1985, Allergy to antibiotic (Doxycycline), Allergy to antibiotic (Tetracycline) and Allergy to antibiotic (Minocin). Concomitant products included BUPROPION from 01-Sep-1997 to an unknown date for Depression, SIMVASTATIN from 19-Oct-2000 to an unknown date for Hypercholesterolaemia, HYDROXYCHLOROQUINE from 10-Jan-2002 to an unknown date for Rheumatoid arthritis, TRAZODONE from 07-Jun-2019 to an unknown date for Sleep disorder, ATENOLOL from 10-Jan-2002 to an unknown date for Supraventricular tachycardia.   On 04-Feb-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021 at 3:06 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Blood test after second dose, result came back as negative- no antibody count). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Blood test after second dose, result came back as negative- no antibody count) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-022851 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow-up received 03-Aug-2021 contains no new information.
Cardiac and pleuritic pain, shortness of breath, dizziness, heart palpitations, tachycardia, difficulty breathing, fatigue
PATIENT REPORTS TO HAVING FATIGUE FOR 2-3 WEEKS FOLLOWING ADMINISTRATION OF 1ST DOSE OF COVID-19 VACCINE.  2ND DOSE WAS ADMINISTERED. NO REPORTS OF SIDE EFFECTS BY THE END  OF 2ND DOSE APPOINTMENT.
Soreness at the injection site (right arm) beginning at the time of administration. Soreness in the shoulders, lower back, pelvic area begging at the onset of the adverse reaction and increasing since that time. Soreness severe band limited body movement and function.
Diarrhea started about 8 hours after injection - has been persistent for several days but calming down now
Family friend believes Pfizer vaccine caused shingles; This is a spontaneous report from a contactable consumer or other non hcp. A 55-years-old non-pregnant female patient received bnt162b2 (BNT162B2) formulation solution for injection, (Lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date in Apr2021 (at the age of 55-years-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Other medications in two weeks: not known. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02May2021 the patient experienced family friend believes pfizer vaccine caused shingles. Therapeutic measures were taken as a result of family friend believes pfizer vaccine caused shingles. Outcome of the events was not recovered.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Patient was extremely anxious prior to receiving Pfizer IM injection. Once she received the vaccination she reported that she was having ?trouble breathing?. She stated she has asthma and that she needed her inhaler. She pulled a benadryl from her pocket and took it. Patient denied feeling any swelling in her throat. Two nurses stayed with the patient until she stated she was feeling better. Nurse escorted the patient to the observation area. After sitting in the observation area for several minutes the patient had used her inhaler and stated that she felt like she was going to pass out. 911 was called, the patient was assisted to the floor, vitals were monitored BP 170/90 HR 148 R16; Spo2 100%. Both Nurses stayed with the patient until EMS arrived to educate relaxation techniques and deep breathing. Patient was taken to the hospital via ambulance.  While waiting for EMS that patient had called her daughter and stated she was having a ?panic attack? her daughter stated ?what is wrong with you, you need to get help?. Patient reports having a long history with anxiety.
Bad thought, Persistent migraines for days on days, body aches & pains all over. Use to be healthy athlete now can?t workout with pain. All symptoms come from 1-2 weeks after vaccine. Have been to hospital, ER, Neurologist, experienced memory loss as well.. every day is physical struggle.
Patient experienced redness, swelling, and a very painful reaction to receiving the flu vaccine. Patient visited an urgent care, where reaction was diagnosed as cellulitis. Patient received antibiotics from urgent care on Thursday, 11/7. Reaction has since resolved with use of antibiotics.
ALOPECIA AREATA:I received my first shot of Gardasil in January 2007. About a month later we noticed a bald spot in the back of my head. I went back to my ObGyn and asked her if the Gardasil could be the cause as nothing else had recenlty changed and I was not taking any ther medications. She said that she had not heard of this, but she referred me to a dermatologist. I asked him if my hair loss had anything to do with the Gardasil. He replied that I had Alopecia areata and one thing had nothing to do with the other. He advised that I continue with the Gardasil and that he would start treating me for the alopecia. I believe that the Gardasil is the cause of my Alopecia, now over half of my head is bald.  I don't know what to do. I keep going back to the dermatologist for treatments for the alopecia, but it just keeps getting worse.
Pt felt sick; fell and hit her head, had fever of 102.1 also chills.   Treatment if any is not known.
left deltoid site reaction with round area of erythema approx 2 inches in diameter. flat. no elevation. not warm. no fever
Patient fainted within 2 minutes of receiving vaccination. Father was holding patient in her chair and she regained her conscience within 10 seconds. Patient felt nauseas and vomited about 5 minutes later. We provided patient some water and monitored her for 30 minutes. She was calm and felt fine when she was leaving the pharmacy.
Flu shot 9/19/2010. Pt had low grade fevers 9/20/2010. Pt with whole body hives 9/22/2010 until now. No SOB, wheezing, lip/tongue swelling. Currently in treatment with antihistamine.
Pt developed swelling from elbow to underarm on left arm, redness, inflamed, swollen; flu-like symptom throughout body, headache, chills, nausea, joint pain in upper extremities (fingers, elbow).
A month ago a nodule appeared located on the left mid collarbone.  One big one and one little one.
Received Paxlovid for COVID-19 Treatment on 10Dec2022 to 14Dec2022; Received Paxlovid for COVID-19 Treatment on 10Dec2022 to 14Dec2022; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Oct2022 as dose 4 (booster), single (Lot number: GJ6665) at the age of 49 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Jan2021 as dose 1, single (Lot number: EL9261), in left arm, on 22Feb2021 as dose 2, single (Lot number: EN6200), in right arm and on 02Nov2021 as dose 3 (booster), single (Lot number: FH8028), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "Hypercholesteremia" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing); "known_allergies sulfa meds" (unspecified if ongoing), notes: audio and photosensitivity. The patient took concomitant medications which included thyroid medications & antidepressants and cholesterol medications. Past drug history included: Bactrim, reaction(s): "photosensitivity"; Bactrim, reaction(s): "audio sensitivity". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Received Paxlovid for COVID-19 Treatment on 10Dec2022 to 14Dec2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Dec2022) Negative, notes: 3 Days post negative test and end of 5 day course on 14Dec2022; (17Dec2022) Positive, notes: Paxlovid rebound with positive test on 17Dec2022. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drugs BNT162B2 and BNT162b2, BNT162b2 omi ba.4-5 cannot be excluded. The case will be reassessed once new information is available.
Experienced claminess, itching, teeth/jaw shaking.  Symptom onset approximately 3.5 hrs after vaccination.  Rash developed at 0115 on 10/2/08 and employee went to ED.  Treatment included saline, benadryl, solumedrol, tagmet.  Employee sent home after ED visit.
dizzy, h/a, n/v, pain edema lt arm, achiness, malaise; (no edema or pain rt arm);
A FEW MINUTES AFTER VACCINE WAS ADMINISTERED PATIENT BEGAN RUBBING SITE AND COMPLAINING IT WAS ITCHY. NURSE VISUALLY EXAMINED ARM & SAW NO WELPS OR HIVES.  PHYSICIA ORDERED BENADRYL WHICH PATIENT REFUSED TO TAKE.  DID NOT ALLOW PHYSICIAN TO EXAMINE.  PATIENT WAS MONITORED FOR ANOTHER 20 MIN & DID NOT DEVELOP FURTHER SIGNS OR SYMPTOMS OF ALLERGIC REACTION & DID NOT COMPLAIN OF ITCHING FURTHER.
Client  received Pfizer monovalent vaccine (FT1511) instead of bivalent vaccine.   Had already completed 2 doses of primary series.  No adverse effects.  Mother notified later that day.  Mom aware to return in greater than 2 months for booster.
Caller states last night her daughter developed a sore throat that is lasting into today; Caller states her daughter had a sore arm which was to be expected; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the parent.  A 14 year-old female patient received bnt162b2 (BNT162B2), administration date 15May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15May2021, outcome "unknown", described as "Caller states her daughter had a sore arm which was to be expected"; OROPHARYNGEAL PAIN (non-serious) with onset 16May2021, outcome "not recovered", described as "Caller states last night her daughter developed a sore throat that is lasting into today". Therapeutic measures were taken as a result of oropharyngeal pain.  Additional information: Patient took Advil for sore throat.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever 37.1 , headache, shivering from coldness, body aches and weakness, soreness in my left upper arm.
pt began running t102-103 w/in 2hr p/vax;cont to run fever for 3 days & 8AM w/apnea;pt taken to ER; had 4 small (petit mal) sz, t103; no further sz;
bone pain; flu like sumptoms; muscle pain; chills; fever; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of BONE PAIN (bone pain), INFLUENZA LIKE ILLNESS (flu like sumptoms), MYALGIA (muscle pain), CHILLS (chills) and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (bone pain), INFLUENZA LIKE ILLNESS (flu like sumptoms), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, BONE PAIN (bone pain), INFLUENZA LIKE ILLNESS (flu like sumptoms), MYALGIA (muscle pain), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant product use was reported  No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Additional information received on 27-APR-2021 and does not contain any new information
pt recvd vax & 13 days later exp urticaria; treated w/Medrol Dosepak (methylprednisolone), IV Solu-Medrol (methylprednisolone sodium succinate), & Pred PO;
Tinnitus was noted several days after the vaccination and has been persistent; This is a spontaneous report from a contactable physician. A 49-year-old male patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) intramuscularly in the right arm on 11Mar2021 (at the age of 49-year-old) at 11:00 as a single dose for COVID-19 immunisation. The patient's medical history included hypertension. Concomitant medication included losartan (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. No allergies to medications, food, or other products had been reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 12Mar2021 at 08:00, patient experienced tinnitus, was noted several days after the vaccination and had been persistent. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The outcome of the event tinnitus was noted several days after the vaccination and had been persistent was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.
has not yet received second dose of Shingrix; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received approximately 1 year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
injection site swelling; The injection site is red; itches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site swelling), INJECTION SITE ERYTHEMA (The injection site is red) and INJECTION SITE PRURITUS (itches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concomitant products included FLUOROMETHOLONE, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ACETYLSALICYLIC ACID (ASPRIN).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site swelling), INJECTION SITE ERYTHEMA (The injection site is red) and INJECTION SITE PRURITUS (itches). At the time of the report, INJECTION SITE SWELLING (injection site swelling), INJECTION SITE ERYTHEMA (The injection site is red) and INJECTION SITE PRURITUS (itches) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Applied cortisone cream and sprayed Flonase as treatment.
Headache, fever body aches Narrative: Woke up with Fever, body aches, slight headache. Is self monitoring at home taking acetaminophen as needed. Feeling better
Arm pain for one day could not lift arm above chest following vaccine on 3/10/2021. Treated with ice.   Intense lower abdomen pain started on 3/17/2021 Went to ER. Kidney infection   Treated with IV Morphine Iv Fluids, Cefuroxime
Red spot on arm 10 am, sore arm 10 am, chills 8pm, fever10 pm til 8 am took Tylenol , headaches from 10pm til 8am took excedrin headache
Tenderness in the injection site muscle; This spontaneous case was reported by a dental hygienist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Tenderness in the injection site muscle) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (Tenderness in the injection site muscle). At the time of the report, VACCINATION SITE PAIN (Tenderness in the injection site muscle) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact
arm was more swollen, red and hard at injection site.; arm was more swollen, red and hard at injection site.; arm was more swollen, red and hard at injection site.; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE INDURATION (arm was more swollen, red and hard at injection site.), VACCINATION SITE SWELLING (arm was more swollen, red and hard at injection site.) and VACCINATION SITE ERYTHEMA (arm was more swollen, red and hard at injection site.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Mar-2021, the patient experienced VACCINATION SITE INDURATION (arm was more swollen, red and hard at injection site.), VACCINATION SITE SWELLING (arm was more swollen, red and hard at injection site.) and VACCINATION SITE ERYTHEMA (arm was more swollen, red and hard at injection site.). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE INDURATION (arm was more swollen, red and hard at injection site.), VACCINATION SITE SWELLING (arm was more swollen, red and hard at injection site.) and VACCINATION SITE ERYTHEMA (arm was more swollen, red and hard at injection site.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter stated that the patient was taking concomitant medications but did not specify. No treatment medications were given.
Deep muscle pain in the left shoulder, radiating up neck, radiating down the bicep, wrist pain and numb hand.
When I received vaccine I had a uri/sinusitis illness without fever.  One day later I had body aches, chills, headache, no fever, these symptoms lasted 2.5 weeks.  2 days after receiving vaccine I had scrotal and ankle edema and a 3 kg weight gain that lasted 5 days.   I also developed a worsening of uri and cough symptoms, which now 3 weeks later are slowly resolving
Chills for 24 hours; Aches and pains for 24 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CHILLS (non-serious), outcome "recovered", described as "Chills for 24 hours"; PAIN (non-serious), outcome "recovered", described as "Aches and pains for 24 hours".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021459175 same reporter/vaccine, similar event, and different patient.
Pt recvd DTP/HIB in the MA, that afternoon t105.4 was very tired, looked purple but no LOC; workup shows UTI dx on cath UA & urine C&S; no sz, LOC; on IV antibiotics in hosp for UTI;